This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mark Your Calendar for Next Year's Event!
May 9-12, 2022Hynes Convention Center, Boston

Hybio Pharmaceuticals

Profile

As the first listed peptide producer and a leading manufacturer in China, Hybio Pharmaceutical is focusing on R&D and commercialization of therapeutic peptides API, peptide-based drugs for over 20 years.


Our in-house market research and analytics team meticulously selects APIs that provide a unique and competitive market proposition to our customers. Backed by decades of global market development, and with outstanding R&D, expert regulatory team, US/EU GMP standard quality and up to 500kg annual production capability, Hybio is well placed to support your projects and together with you to fulfill the goals.